| BHYAX | NCOIX | BHYAX / NCOIX | |
| Total Expense Ratio | 0.93 | 0.76 | 122% |
| Annual Report Gross Expense Ratio | 0.95 | 0.83 | 114% |
| Fund Existence | 27 years | 16 years | - |
| Gain YTD | 7.009 | 6.029 | 116% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 1000 | 100000 | 1% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 26.2B | 557M | 4,704% |
| Annual Yield % from dividends | 6.39 | 7.84 | 81% |
| Returns for 1 year | 7.02 | 6.94 | 101% |
| Returns for 3 years | 31.26 | 31.99 | 98% |
| Returns for 5 years | 25.77 | 29.16 | 88% |
| Returns for 10 years | 70.29 | 79.75 | 88% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TSDD | 11.44 | 0.49 | +4.47% |
| GraniteShares 2x Short TSLA Daily ETF | |||
| SAY | 25.25 | 0.03 | +0.12% |
| Saratoga Investment Corp | |||
| JPI | 20.68 | N/A | N/A |
| Nuveen Preferred Securities & Income Opportunities Fund | |||
| SYNB | 31.61 | N/A | N/A |
| Putnam BioRevolution ETF | |||
| EUSA | 98.57 | -1.32 | -1.32% |
| iShares MSCI USA Equal Weighted ETF | |||